These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3668456)

  • 1. Relation between cigarette smoking and use of hormonal replacement therapy for menopausal symptoms.
    Greenberg G; Thompson SG; Meade TW
    J Epidemiol Community Health; 1987 Mar; 41(1):26-9. PubMed ID: 3668456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and characteristics associated with use of hormone replacement therapy in Britain.
    Moorhead T; Hannaford P; Warskyj M
    Br J Obstet Gynaecol; 1997 Mar; 104(3):290-7. PubMed ID: 9091004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study.
    Li C; Samsioe G; Lidfelt J; Nerbrand C; Agardh CD;
    Menopause; 2000; 7(4):273-81. PubMed ID: 10914621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy and previous use of oral contraceptives among Swedish women.
    Hammar M; Brynhildsen J; Dabrosin L; Frisk J; Lindgren R; Nedstrand E; Wyon Y
    Maturitas; 1996 Nov; 25(3):193-9. PubMed ID: 8981336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Climacteric symptoms and knowledge about hormone replacement therapy among Hong Kong Chinese women aged 40-60 years.
    Lam PM; Leung TN; Haines C; Chung TK
    Maturitas; 2003 Jun; 45(2):99-107. PubMed ID: 12787968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of hormone replacement therapy by menopausal women in six family-practice teaching clinics in Israel.
    Vinker S; Kaplan B; Yaphe J; Cohen O; Shumla V; Shapira G; Shofty I; Kitai E
    Climacteric; 2003 Mar; 6(1):75-80. PubMed ID: 12725667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The view of women aged 45-65 and their partners on aspects of the climacteric phase of life.
    Barentsen R; Foekema HA; Bezemer W; van Stiphout FL
    Eur J Obstet Gynecol Reprod Biol; 1994 Nov; 57(2):95-101. PubMed ID: 7859912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
    Windler E; Zyriax BC; Eidenmüller B; Boeing H
    Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone replacement therapy: I. A pharmacoeconomic appraisal of its therapeutic use in menopausal symptoms and urogenital estrogen deficiency.
    Whittington R; Faulds D
    Pharmacoeconomics; 1994 May; 5(5):419-45. PubMed ID: 10147233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with climacteric symptoms and the use of hormone replacement therapy.
    Stadberg E; Mattsson LA; Milsom I
    Acta Obstet Gynecol Scand; 2000 Apr; 79(4):286-92. PubMed ID: 10746844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of climacteric symptoms in breast cancer patients: a retrospective study from a medication databank.
    Antoine C; Ameye L; Paesmans M; Rozenberg S
    Maturitas; 2014 Jul; 78(3):228-32. PubMed ID: 24852403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of endogenous and exogenous hormones on breast cancer: epidemiology.
    Vessey MP
    Verh Dtsch Ges Pathol; 1997; 81():493-501. PubMed ID: 9474890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral symptoms at menopause--the role of hormone replacement therapy.
    Tarkkila L; Linna M; Tiitinen A; Lindqvist C; Meurman JH
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Sep; 92(3):276-80. PubMed ID: 11552144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution.
    Norman RJ; Flight IH; Rees MC
    Cochrane Database Syst Rev; 2000; (2):CD001018. PubMed ID: 10796730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why do women doctors in the UK take hormone replacement therapy?
    Isaacs AJ; Britton AR; McPherson K
    J Epidemiol Community Health; 1997 Aug; 51(4):373-7. PubMed ID: 9328541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of hormone replacement therapy among postmenopausal women enrolled in the French GAZEL cohort.
    Ringa V; Ledésert B; Bréart G
    Osteoporos Int; 1994 Jan; 4(1):16-20. PubMed ID: 8148567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlates of hormone replacement therapy use in Italian women, 1992-1996.
    Chiaffarino F; Parazzini F; La Vecchia C; Bianchi MM; Benzi G; Ricci E; Chiantera V
    Maturitas; 1999 Oct; 33(2):107-15. PubMed ID: 10597874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Estrogen and natural products in the treatment of postmenopausal complaints. Oral contraceptives prepare the way for hormonal substitution].
    Hammar M; Frisk J; Brynhildsen J; Dabrosin L; Lindgren R; Nedstrand E; Wyon Y
    Lakartidningen; 1997 Mar; 94(12):1084-8. PubMed ID: 9121242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hormonal replacement therapy on skin biophysical properties of menopausal women.
    Guinot C; Malvy D; Ambroisine L; Latreille J; Mauger E; Guéhenneux S; Morizot F; Tschachler E
    Skin Res Technol; 2005 Aug; 11(3):201-4. PubMed ID: 15998332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.